Because patients who discontinued WEGOVY injection during titration and those who did not reach the 2.4 mg weekly dose were not eligible for the randomized-treatment period, the results may not reflect the experience of patients in the general population who are first starting WEGOVY injection
We will look at the science behind the cancer warnings, how these medications can affect the absorption of existing thyroid treatments, and why significant weight loss can change your hormone requirements
Empire Medical Training's Advanced Weight Management Certification covers GLP-1 agonists including semaglutide alongside the wider medical weight-loss toolkit, taught for practitioners building or expanding a supervised programme.
87(4): 3438 Aviles-Olmos I, Limousin P, Lees A, et al
They're sold at wellness spas and directly online
In the STEP 1 trial published in the New England Journal of Medicine (2021), participants receiving semaglutide 2.4 mg weekly achieved an average weight loss of approximately 15% of body weight over 68 weeks, compared to 2.4% with placebo